CSNpharm

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Ranitidine HCl 100mg  | ≥99%

CSNpharm

Ranitidine HCl is an antagonist of histamine H2-receptor that can inhibit stomach acid production.

More Information Supplier Page

×

Ranitidine HCl

Ranitidine HCl 250mg  | ≥99%

CSNpharm

Ranitidine HCl is an antagonist of histamine H2-receptor that can inhibit stomach acid production.

More Information Supplier Page

×

Ranitidine HCl

Ranolazine 250mg  | ≥99%

CSNpharm

Ranolazine inhibits calcium uptake via the sodium/calcium channel, is used to treat chronic angina.

More Information Supplier Page

×

Ranolazine

Ranolazine 100mg  | ≥99%

CSNpharm

Ranolazine inhibits calcium uptake via the sodium/calcium channel, is used to treat chronic angina.

More Information Supplier Page

×

Ranolazine

Ranolazine 2HCl 1g  | ≥98%

CSNpharm

Ranolazine 2HCl is a calcium uptake inhibitor via the sodium/calcium channal, used to treat chronic angina.

More Information Supplier Page

×

Ranolazine 2HCl

Ranolazine 2HCl 250mg  | ≥98%

CSNpharm

Ranolazine 2HCl is a calcium uptake inhibitor via the sodium/calcium channal, used to treat chronic angina.

More Information Supplier Page

×

Ranolazine 2HCl

Ranolazine 2HCl 100mg  | ≥98%

CSNpharm

Ranolazine 2HCl is a calcium uptake inhibitor via the sodium/calcium channal, used to treat chronic angina.

More Information Supplier Page

×

Ranolazine 2HCl

Ranolazine 2HCl 5g  | ≥98%

CSNpharm

Ranolazine 2HCl is a calcium uptake inhibitor via the sodium/calcium channal, used to treat chronic angina.

More Information Supplier Page

×

Ranolazine 2HCl

Rapamycin 100mg  | ≥98%

CSNpharm

Rapamycin is a specific mTOR inhibitor with IC50 of ~0.1 nM.

More Information Supplier Page

×

Rapamycin

Rapamycin 250mg  | ≥98%

CSNpharm

Rapamycin is a specific mTOR inhibitor with IC50 of ~0.1 nM.

More Information Supplier Page

×

Rapamycin

Rapamycin 50mg  | ≥98%

CSNpharm

Rapamycin is a specific mTOR inhibitor with IC50 of ~0.1 nM.

More Information Supplier Page

×

Rapamycin

Rapamycin 10mg  | ≥98%

CSNpharm

Rapamycin is a specific mTOR inhibitor with IC50 of ~0.1 nM.

More Information Supplier Page

×

Rapamycin

Rapastinel 10mg  | ≥99%

CSNpharm

Rapastinel is a putative NMDAR functional glycine-site partial agonist.

More Information Supplier Page

×

Rapastinel

Rapastinel 25mg  | ≥99%

CSNpharm

Rapastinel is a putative NMDAR functional glycine-site partial agonist.

More Information Supplier Page

×

Rapastinel

Rapastinel 1mg  | ≥99%

CSNpharm

Rapastinel is a putative NMDAR functional glycine-site partial agonist.

More Information Supplier Page

×

Rapastinel

Rapastinel 5mg  | ≥99%

CSNpharm

Rapastinel is a putative NMDAR functional glycine-site partial agonist.

More Information Supplier Page

×

Rapastinel

Rasagiline Mesylate 50mg  | ≥99%

CSNpharm

Rasagiline Mesylate is an irreversible and selective MAO-B inhibitor used in early Parkinson’s disease.

More Information Supplier Page

×

Rasagiline Mesylate

Rasagiline Mesylate 100mg  | ≥99%

CSNpharm

Rasagiline Mesylate is an irreversible and selective MAO-B inhibitor used in early Parkinson’s disease.

More Information Supplier Page

×

Rasagiline Mesylate

Ravenine 1mg  | ≥98%

CSNpharm

Ravenine is a natural product isolated and purified from Ammi visnaga (L.) Lam..

More Information Supplier Page

×

Ravenine

Ravenine 5mg  | ≥98%

CSNpharm

Ravenine is a natural product isolated and purified from Ammi visnaga (L.) Lam..

More Information Supplier Page

×

Ravenine

RCGD423 10mg  | ≥97%

CSNpharm

RCGD423 is a gp130 modulator, which prevents articular cartilage degeneration and promotes repair.

More Information Supplier Page

×

RCGD423

RCGD423 1mg  | ≥97%

CSNpharm

RCGD423 is a gp130 modulator, which prevents articular cartilage degeneration and promotes repair.

More Information Supplier Page

×

RCGD423

RCGD423 25mg  | ≥97%

CSNpharm

RCGD423 is a gp130 modulator, which prevents articular cartilage degeneration and promotes repair.

More Information Supplier Page

×

RCGD423

RCGD423 5mg  | ≥97%

CSNpharm

RCGD423 is a gp130 modulator, which prevents articular cartilage degeneration and promotes repair.

More Information Supplier Page

×

RCGD423

RCGD423 100mg  | ≥97%

CSNpharm

RCGD423 is a gp130 modulator, which prevents articular cartilage degeneration and promotes repair.

More Information Supplier Page

×

RCGD423

RCGD423 50mg  | ≥97%

CSNpharm

RCGD423 is a gp130 modulator, which prevents articular cartilage degeneration and promotes repair.

More Information Supplier Page

×

RCGD423

RD3-0028 1mg  | ≥98%

CSNpharm

RD3-0028 is a potent and selective inhibitor of RSV replication with an EC50 of 4.5 μM.

More Information Supplier Page

×

RD3-0028

RD3-0028 5mg  | ≥98%

CSNpharm

RD3-0028 is a potent and selective inhibitor of RSV replication with an EC50 of 4.5 μM.

More Information Supplier Page

×

RD3-0028

RD3-0028 10mg  | ≥98%

CSNpharm

RD3-0028 is a potent and selective inhibitor of RSV replication with an EC50 of 4.5 μM.

More Information Supplier Page

×

RD3-0028

Rebamipide 1g  | ≥98%

CSNpharm

Rebamipide is an inducer of endogenous prostaglandin, an oxygen-derived free radical scavenger, and a cholecystokinin type 1 (CCK1) receptor inhibitor for inhibiting [125I]BH-CCK-8S with IC50 of 37.7 μM.

More Information Supplier Page

×

Rebamipide

Rebamipide 5g  | ≥98%

CSNpharm

Rebamipide is an inducer of endogenous prostaglandin, an oxygen-derived free radical scavenger, and a cholecystokinin type 1 (CCK1) receptor inhibitor for inhibiting [125I]BH-CCK-8S with IC50 of 37.7 μM.

More Information Supplier Page

×

Rebamipide

Rebaudioside A 25mg  | ≥98%

CSNpharm

Rebaudioside A, an α-glucosidase inhibitor with IC50 of 35.01 μg/mL. is a steviol glycoside isolated and purified from the leaves of Stevia rebaudiana Bertoni..

More Information Supplier Page

×

Rebaudioside A

Rebaudioside A 100mg  | ≥98%

CSNpharm

Rebaudioside A, an α-glucosidase inhibitor with IC50 of 35.01 μg/mL. is a steviol glycoside isolated and purified from the leaves of Stevia rebaudiana Bertoni..

More Information Supplier Page

×

Rebaudioside A

Reboxetine Mesylate 50mg  | ≥99%

CSNpharm

Reboxetine Mesylate is a norepinephrine reuptake inhibitor (NRI) used in the treatment of unipolar depression.

More Information Supplier Page

×

Reboxetine Mesylate

Reboxetine Mesylate 5mg  | ≥99%

CSNpharm

Reboxetine Mesylate is a norepinephrine reuptake inhibitor (NRI) used in the treatment of unipolar depression.

More Information Supplier Page

×

Reboxetine Mesylate

Reboxetine Mesylate 10mg  | ≥99%

CSNpharm

Reboxetine Mesylate is a norepinephrine reuptake inhibitor (NRI) used in the treatment of unipolar depression.

More Information Supplier Page

×

Reboxetine Mesylate

Regadenoson 2mg  | ≥99%

CSNpharm

Regadenoson is a selective adenosine A2A receptor agonist with Ki value of 1.1nM for pig striatum A2A receptor, used as a novel pharmacologic stress agent under clinical development for myocardial perfusion imaging.

More Information Supplier Page

×

Regadenoson

Regadenoson 10mg  | ≥99%

CSNpharm

Regadenoson is a selective adenosine A2A receptor agonist with Ki value of 1.1nM for pig striatum A2A receptor, used as a novel pharmacologic stress agent under clinical development for myocardial perfusion imaging.

More Information Supplier Page

×

Regadenoson

Regadenoson 25mg  | ≥99%

CSNpharm

Regadenoson is a selective adenosine A2A receptor agonist with Ki value of 1.1nM for pig striatum A2A receptor, used as a novel pharmacologic stress agent under clinical development for myocardial perfusion imaging.

More Information Supplier Page

×

Regadenoson

Regadenoson 50mg  | ≥99%

CSNpharm

Regadenoson is a selective adenosine A2A receptor agonist with Ki value of 1.1nM for pig striatum A2A receptor, used as a novel pharmacologic stress agent under clinical development for myocardial perfusion imaging.

More Information Supplier Page

×

Regadenoson

Regadenoson 5mg  | ≥99%

CSNpharm

Regadenoson is a selective adenosine A2A receptor agonist with Ki value of 1.1nM for pig striatum A2A receptor, used as a novel pharmacologic stress agent under clinical development for myocardial perfusion imaging.

More Information Supplier Page

×

Regadenoson

Remoxipride 1g  | ≥98%

CSNpharm

Remoxipride is an atypical antipsychotic which was previously used in Europe for the treatment of schizophrenia and acute mania but was withdrawn due to toxicity concerns (incidence of aplastic anemia in 1/10,000 patients).

More Information Supplier Page

×

Remoxipride

Repaglinide 50mg  | ≥99%

CSNpharm

Repaglinide is a carbamoylmethyl benzoic acid (CMBA) derivative, which recently has become available for the treatment of type II diabetes.

More Information Supplier Page

×

Repaglinide

Repaglinide 100mg  | ≥99%

CSNpharm

Repaglinide is a carbamoylmethyl benzoic acid (CMBA) derivative, which recently has become available for the treatment of type II diabetes.

More Information Supplier Page

×

Repaglinide

Repaglinide 10mg  | ≥99%

CSNpharm

Repaglinide is a carbamoylmethyl benzoic acid (CMBA) derivative, which recently has become available for the treatment of type II diabetes.

More Information Supplier Page

×

Repaglinide

Reparixin 250mg  | ≥99%

CSNpharm

Reparixin is an inhibitor of CXCL8 receptor, also inhibit CXCR1 and CXCR2 activation, which has been shown to attenuate inflammatory responses in various injury models.

More Information Supplier Page

×

Reparixin

Reparixin 5mg  | ≥99%

CSNpharm

Reparixin is an inhibitor of CXCL8 receptor, also inhibit CXCR1 and CXCR2 activation, which has been shown to attenuate inflammatory responses in various injury models.

More Information Supplier Page

×

Reparixin

Reparixin 50mg  | ≥99%

CSNpharm

Reparixin is an inhibitor of CXCL8 receptor, also inhibit CXCR1 and CXCR2 activation, which has been shown to attenuate inflammatory responses in various injury models.

More Information Supplier Page

×

Reparixin

Reparixin 10mg  | ≥99%

CSNpharm

Reparixin is an inhibitor of CXCL8 receptor, also inhibit CXCR1 and CXCR2 activation, which has been shown to attenuate inflammatory responses in various injury models.

More Information Supplier Page

×

Reparixin

Reparixin 100mg  | ≥99%

CSNpharm

Reparixin is an inhibitor of CXCL8 receptor, also inhibit CXCR1 and CXCR2 activation, which has been shown to attenuate inflammatory responses in various injury models.

More Information Supplier Page

×

Reparixin